Human cytomegalovirus glycoprotein UL141 targets the TRAIL death receptors to thwart host innate antiviral defenses. (2013)

First Author: Smith W
Attributed to:  Development of adenovirus type 4 vectors for immunotherapeutic application funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.chom.2013.02.003

PubMed Identifier: 23498957

Publication URI: http://europepmc.org/abstract/MED/23498957

Type: Journal Article/Review

Volume: 13

Parent Publication: Cell host & microbe

Issue: 3

ISSN: 1931-3128